Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $18.1400 (-0.11%) ($17.8700 - $18.3200) on Wed. Dec. 6, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.57% (three month average) | RSI | 51 | Latest Price | $18.1400(-0.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.5% a day on average for past five trading days. | Weekly Trend | HALO declines -0.9% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(57%) IWO(55%) XBI(54%) IWM(51%) ARKG(50%) | Factors Impacting HALO price | HALO will decline at least -1.785% in a week (0% probabilities). VIXM(-12%) UUP(-12%) TLT(-6%) SHY(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.785% (StdDev 3.57%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
Resistance Level | $18.52 | 5 Day Moving Average | $18.29(-0.82%) | 10 Day Moving Average | $18.46(-1.73%) | 20 Day Moving Average | $18.52(-2.05%) | To recent high | -5.5% | To recent low | 39.9% | Market Cap | $2.479b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |